REG3A and familial pancreatic carcinoma: These data suggested that, as a secreted molecule highly expressed in pancreatic cancer and related to the clinical outcome of patients, Reg3A might be an effective biomarker enabling the earlier diagnosis, earlier therapeutic intervention, prognosis and stratification of patients with this deadly disease.